← back to search

Ying Xing

Nanjing University of Science and Technology · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Ubiquitin and proteasome pathways, and Selenium in Biological Systems.
h-index
28
citations
2,576
works
183
NIH funding
primary concept
email

Recent publications

Molecular interactions and binding mechanisms of the homogalacturonan and rhamnogalacturonan-I fractions of pectin and different anthocyanins
Food Research International 2025cited by 11position: firstdoi
m <sup>6</sup> A‐modified EHD1 controls PD‐L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma
Cancer Communications 2025cited by 2position: middledoi
Endothelial PIEZO1 activation impairs osteogenesis via GREM1-mediated inhibition of BMP signaling
Cell Calcium 2025cited by 1position: middledoi
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
JAMA Neurology 2024cited by 27position: middledoi
m<sup>6</sup>A‐Modified SNRPA Controls Alternative Splicing of ERCC1 Exon 8 to Induce Cisplatin Resistance in Lung Adenocarcinoma
Advanced Science 2024cited by 24position: lastdoi
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma
Cancer Cell International 2024cited by 19position: middledoi
Targeting piRNA‐137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via <i>De Novo</i> Cholesterol Biosynthesis in Lung Adenocarcinoma
Advanced Science 2024cited by 14position: lastdoi
Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
BMC Cancer 2023cited by 12position: middledoi
TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA
International Journal of Biological Sciences 2022cited by 44position: middledoi
A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma
Clinical and Translational Medicine 2022cited by 33position: lastdoi
A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
Frontiers in Oncology 2022cited by 9position: lastdoi
Apatinib plus etoposide as second-or higher-line treatment in recurrent or metastatic triple-negative breast cancer: A single-arm, open label, prospective, phase II clinical trial.
Journal of Clinical Oncology 2022cited by 1position: middledoi
Neutrophil Extracellular Traps Exacerbate Ischemic Brain Damage
Molecular Neurobiology 2021cited by 120position: middledoi
A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer
Cancer Letters 2021cited by 28position: middledoi
The Anti-apoptosis Effect of Single Electroacupuncture Treatment via Suppressing Neuronal Autophagy in the Acute Stage of Ischemic Stroke Without Infarct Alleviation
Frontiers in Cellular Neuroscience 2021cited by 21position: firstdoi
Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment
Theranostics 2021cited by 16position: middledoi
Identification of Differentially Expressed Circular RNAs as miRNA Sponges in Lung Adenocarcinoma
Journal of Oncology 2021cited by 13position: lastdoi
LINC02678 as a Novel Prognostic Marker Promotes Aggressive Non-small-cell Lung Cancer
Frontiers in Cell and Developmental Biology 2021cited by 9position: middledoi
Identification of lncRNA–miRNA–mRNA Networks Linked to Non-small Lung Cancer Resistance to Inhibitors of Epidermal Growth Factor Receptor
Frontiers in Genetics 2021cited by 9position: middledoi
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
Frontiers in Cell and Developmental Biology 2021cited by 8position: lastdoi
Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma
Journal of Oncology 2021cited by 4position: middledoi
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
Frontiers in Cellular Neuroscience 2020cited by 87position: middledoi
Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
Frontiers in Cell and Developmental Biology 2020cited by 23position: lastdoi
The role of exosomes in stroke
Molecular Biology Reports 2020cited by 16position: middledoi
CUEDC1 inhibits epithelial-mesenchymal transition via the T&amp;#x3B2;RI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer
Aging 2020cited by 13position: lastdoi
Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling
Frontiers in Oncology 2020cited by 8position: middledoi
Targeting 14-3-3ζ overcomes resistance to EGFR-TKI in lung adenocarcinoma via BMP2/Smad/ID-1 signaling
2020cited by 1position: middledoi
Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC
Oncogene 2019cited by 64position: lastdoi
PADI4‑mediated epithelial‑mesenchymal transition in lung cancer cells
Molecular Medicine Reports 2019cited by 28position: middledoi
Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling
Journal of Experimental & Clinical Cancer Research 2019cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Li Cai · Zhengzhou University24 papers (2015–2025)Weina Fan · Harbin Medical University11 papers (2019–2025)Fanglin Tian · University of California, Berkeley11 papers (2019–2025)Yuechao Liu · Harbin Medical University10 papers (2017–2022)Mengru Cao · Harbin Medical University9 papers (2018–2024)Yuning Zhan · Harbin Medical University9 papers (2020–2025)Xuesong Chen · Brown University8 papers (2014–2023)Feng Zhang · Qingdao University8 papers (2018–2021)Yang Song · Fudan University8 papers (2019–2024)Qingwei Meng · Guangdong University of Technology7 papers (2014–2019)Yimeng Cui · Harbin Medical University7 papers (2021–2022)Ruixue Gu · Harbin Medical University7 papers (2019–2022)Fang Dong · Hebei Medical University7 papers (2018–2021)Yaowen Cui · Harbin Medical University7 papers (2021–2022)Ya-Shuo Feng · Fudan University7 papers (2018–2021)Manman Wang · Shandong University of Traditional Chinese Medicine7 papers (2018–2021)Jian Huang · Harbin Medical University6 papers (2018–2021)Hailing Lu · University of Illinois Urbana-Champaign6 papers (2016–2020)Dexin Jia · Harbin Medical University6 papers (2019–2021)Lichun Sun · Fudan University5 papers (2014–2023)